Empower Clinics Inc.
EPWCF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $5 | $4 | $3 | $2 |
| % Growth | 6.7% | 36.1% | 57.9% | – |
| Cost of Goods Sold | $3 | $3 | $1 | $1 |
| Gross Profit | $2 | $1 | $2 | $1 |
| % Margin | 42.2% | 30.9% | 62.8% | 59.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $5 | $4 | $4 |
| SG&A Expenses | $7 | $5 | $5 | $4 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $0 |
| Other Operating Expenses | $0 | $1 | $2 | $3 |
| Operating Expenses | $7 | $7 | $6 | $5 |
| Operating Income | -$5 | -$5 | -$4 | -$4 |
| % Margin | -106.3% | -124.6% | -112.4% | -173% |
| Other Income/Exp. Net | $2 | -$26 | -$13 | -$0 |
| Pre-Tax Income | -$3 | -$32 | -$17 | -$4 |
| Tax Expense | $0 | $0 | $1 | $1 |
| Net Income | -$0 | -$32 | -$17 | -$4 |
| % Margin | -0.1% | -738.3% | -531.8% | -211.7% |
| EPS | -0.041 | -0.5 | -0.48 | -0.2 |
| % Growth | 91.8% | -4.2% | -140% | – |
| EPS Diluted | -0.041 | -0.5 | -0.48 | -0.2 |
| Weighted Avg Shares Out | 70 | 66 | 36 | 23 |
| Weighted Avg Shares Out Dil | 70 | 66 | 36 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $2 | $0 | $1 | $0 |
| Depreciation & Amortization | $0 | $1 | $0 | $0 |
| EBITDA | -$1 | -$31 | -$17 | -$4 |
| % Margin | -23.3% | -703.5% | -518.7% | -186% |